Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Total Debt: 2022-2024

Historic Total Debt for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $391.0 million.

  • Immunocore Holdings' Total Debt rose 0.54% to $392.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.6 million, marking a year-over-year increase of 0.54%. This contributed to the annual value of $391.0 million for FY2024, which is 714.42% up from last year.
  • Immunocore Holdings' Total Debt amounted to $391.0 million in FY2024, which was up 714.42% from $48.0 million recorded in FY2023.
  • Immunocore Holdings' Total Debt's 5-year high stood at $391.0 million during FY2024, with a 5-year trough of $47.8 million in FY2022.
  • For the 3-year period, Immunocore Holdings' Total Debt averaged around $162.3 million, with its median value being $48.0 million (2023).
  • Data for Immunocore Holdings' Total Debt shows a peak YoY surged of 714.42% (in 2024) over the last 5 years.
  • Over the past 3 years, Immunocore Holdings' Total Debt (Yearly) stood at $47.8 million in 2022, then rose by 0.43% to $48.0 million in 2023, then surged by 714.42% to $391.0 million in 2024.